Rua Bioscience Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was NZD 0.016988 million compared to NZD 0.062819 million a year ago. Net loss was NZD 10.85 million compared to net income of NZD 0.718703 million a year ago.

Basic loss per share from continuing operations was NZD 0.069 compared to basic earnings per share from continuing operations of NZD 0.005 a year ago. Diluted loss per share from continuing operations was NZD 0.069 compared to diluted earnings per share from continuing operations of NZD 0.004 a year ago.